Hosted on MSN7mon
Study finds that dopaminergic medication improves sleep quality in Parkinson's disease patients
A study involving 22 Parkinson's disease (PD) patients has shown that use of the dopaminergic drug levodopa improves sleep quality. When the patients took the drug, the number of times they woke ...
AD/PD 2025: Cerevance’s Solengepras falls short of primary endpoint in ASCEND trial
The ASCEND trial evaluated the safety, tolerability, and efficacy of solengepras and aimed to establish its potential to ...
Clinical Trials Arena on MSN3d
Cerevance to proceed with Phase III Parkinson’s trial despite Phase II setback
The pivotal, Phase III study will evaluate the change in average daily “OFF” time in solengepras patients compared to placebo ...
Medscape3mon
Nonmotor Symptoms in Parkinson's Disease: The Dark Side of the Moon
Moreover, a dysfunction of the autonomic nervous system can be induced as a side effect of drug treatment interacting. When dysautonomia is prominent or compared early in the clinical course of ...
TMCnet4d
Cerevance Presents Topline Results from Phase 2 ASCEND Trial of Solengepras as Monotherapy Treatment for Early-Stage Parkinson's Disease at AD/PD 2025
This investigational treatment was generally well tolerated with no serious adverse events; fewer adverse events related to non-motor symptoms were reported in the solengepras arm Pivotal Phase 3 ...